<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Defects in a developmental signaling pathway involving mammalian homologues of the Drosophila segment polarity gene, patched (ptc) and its ligand, sonic hedgehog (shh), contribute to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> formation in several tissues </plain></SENT>
<SENT sid="1" pm="."><plain>Recently, a subset of <z:hpo ids='HP_0002885'>medulloblastoma</z:hpo>, the most common malignant <z:mp ids='MP_0009277'>brain tumor</z:mp> in children, was found to contain <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> in the human ptc gene </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, <z:hpo ids='HP_0002671'>basal cell nevus</z:hpo> syndrome (BCNS), or <z:e sem="disease" ids="C0004779,C0812437" disease_type="Disease or Syndrome;Neoplastic Process" abbrv="">Gorlin syndrome</z:e>, which is characterized by developmental anomalies and a predisposition to skin and <z:mp ids='MP_0008912'>nervous</z:mp> system <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, is associated with germ-line mutation of ptc </plain></SENT>
<SENT sid="3" pm="."><plain>Targeted disruption of both alleles of ptc in mice results in <z:mp ids='MP_0008762'>embryonic lethality</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>However, ptc+/- mice survive and develop spontaneous cerebellar <z:mp ids='MP_0009277'>brain tumors</z:mp>, suggesting that ptc may function as a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor gene </plain></SENT>
<SENT sid="5" pm="."><plain>Therefore, we investigated ptc+/-mice as a model for human <z:hpo ids='HP_0002885'>medulloblastoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>We report that 14% of ptc+/- mice develop central <z:mp ids='MP_0008912'>nervous</z:mp> system <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in the posterior fossa by 10 months of age, with peak <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> incidence occurring between 16 and 24 weeks of age </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> exhibited several characteristics of human <z:hpo ids='HP_0002885'>medulloblastoma</z:hpo>, including expression of intermediate filament proteins specific for neurons and glia </plain></SENT>
<SENT sid="8" pm="."><plain>Full-length ptc <z:chebi fb="2" ids="33699">mRNA</z:chebi> was present in <z:hpo ids='HP_0000001'>all</z:hpo> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> analyzed, indicating that there was no loss of heterozygosity at the ptc locus </plain></SENT>
<SENT sid="9" pm="."><plain>Nucleotide sequence of ptc <z:chebi fb="2" ids="33699">mRNA</z:chebi> from four <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> failed to identify any mutations </plain></SENT>
<SENT sid="10" pm="."><plain>However, a comparison of the <z:mpath ids='MPATH_458'>normal</z:mpath> ptc sequence from C57BL/6 and 129Sv mice did reveal several polymorphisms </plain></SENT>
<SENT sid="11" pm="."><plain>High levels of glil <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein were detected in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, suggesting that the shh/ptc pathway was activated despite the persistence of ptc expression </plain></SENT>
<SENT sid="12" pm="."><plain>These data indicate that haploinsufficiency of ptc is sufficient to promote <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> in the central <z:mp ids='MP_0008912'>nervous</z:mp> system </plain></SENT>
</text></document>